Quantitative Marrow Imaging, Marrow Reserve, And Clinical Outcomes In Patients Undergoing Radiotherapy For Hematologic And Related Disorders

To create a registry for people who are undergoing or previously underwent radiotherapy for hematologic or related disorders.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Quantitative Marrow Imaging Clinical Outcomes Hematologic Marrow Reserve Radiotherapy

Sex eligibility

All sexes

Study type

Observational

Primary location

UT MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location contact

Omran Saifi, MD

CONTACT

[email protected]

832-829-0337

Omran Saifi, MD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Undergoing or previously underwent radiotherapy at The University of Texas MD Anderson Cancer Center for hematologic or related disorders.
Available clinical, imaging, laboratory, treatment, and/or outcome data relevant to study objectives.
Ability to provide informed consent for prospective participation, when applicable.

Exclusion criteria

Participants meeting any of the following criteria will be excluded:

Inability to provide informed consent, or when applicable, the absence of a legally authorized representative able to provide consent for prospective participation.
Insufficient clinical information available to support study objectives.
Pregnant women

Treatment and study plan

Data Collection

Other

The study will collect clinical, imaging, laboratory, treatment, and outcome data from the electronic medical record, radiation treatment planning systems, imaging archives, and other institutional clinical databases

Primary outcomes

Safety and adverse events (AEs).

Time frame: Through study completion; an average of 1 year.

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Study contacts

Contact information is provided by the study sponsor or research team.

Omran Saifi, MD

CONTACT

[email protected]

832-829-0337

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start: 2027
Primary completion: 2036
Study completion: 2038
First posted: Aug 4, 2026
Registry last updated: Aug 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting